Bellerophon Therapeutics Inc (BLPH)
0.0544
0.00 (0.00%)
USD |
OTCM |
Apr 19, 15:28
Bellerophon Therapeutics Total Liabilities (Quarterly): 1.256M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.256M |
| June 30, 2023 | 5.622M |
| March 31, 2023 | 5.364M |
| December 31, 2022 | 5.401M |
| September 30, 2022 | 5.18M |
| June 30, 2022 | 5.45M |
| March 31, 2022 | 5.575M |
| December 31, 2021 | 5.256M |
| September 30, 2021 | 5.524M |
| June 30, 2021 | 6.982M |
| March 31, 2021 | 9.064M |
| December 31, 2020 | 11.99M |
| September 30, 2020 | 11.17M |
| June 30, 2020 | 9.252M |
| March 31, 2020 | 9.432M |
| December 31, 2019 | 9.517M |
| September 30, 2019 | 9.26M |
| June 30, 2019 | 9.116M |
| March 31, 2019 | 14.49M |
| Date | Value |
|---|---|
| December 31, 2018 | 14.50M |
| September 30, 2018 | 19.72M |
| June 30, 2018 | 37.59M |
| March 31, 2018 | 33.67M |
| December 31, 2017 | 39.40M |
| September 30, 2017 | 25.20M |
| June 30, 2017 | 23.14M |
| March 31, 2017 | 24.96M |
| December 31, 2016 | 11.71M |
| September 30, 2016 | 4.788M |
| June 30, 2016 | 6.213M |
| March 31, 2016 | 7.323M |
| December 31, 2015 | 8.073M |
| September 30, 2015 | 8.644M |
| June 30, 2015 | 11.15M |
| March 31, 2015 | 12.79M |
| December 31, 2014 | 10.45M |
| September 30, 2014 | 13.53M |
| December 31, 2013 | 19.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.256M
Minimum
Sep 2023
11.99M
Maximum
Dec 2020
7.245M
Average
6.302M
Median
Total Liabilities (Quarterly) Benchmarks
| Janux Therapeutics Inc | 36.06M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.979M |
| Shareholders Equity (Quarterly) | 3.723M |